Information Services Group, Inc. (III)

Longboard Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	240.2	247.59	291.05	286.27	277.83	249.13
Revenue Growth (YoY)	-9.87%	-14.94%	1.67%	3.04%	11.52%	-6.26%
Cost of Revenue	139.87	150.31	178.91	169.65	168.48	149.88
Gross Profit	100.33	97.28	112.14	116.62	109.36	99.25
Selling, General & Admin	82.76	85.63	91.17	81.57	78.76	80.68
Operating Expenses	87.79	91.52	97.43	86.94	84.09	86.88
Operating Income	12.54	5.76	14.71	29.68	25.27	12.37
Interest Expense	-4.87	-5.84	-6.19	-3.16	-2.34	-3.56
Interest & Investment Income	0.4	0.78	0.5	0.19	0.14	0.26
Currency Exchange Gain (Loss)	-0.11	-0.01	-0.16	0.17	0.04	-0.1
EBT Excluding Unusual Items	7.96	0.7	8.86	26.88	23.11	8.97
Merger & Restructuring Charges	-	-	-0.1	-0.2	-	-2.35
Gain (Loss) on Sale of Assets	4.53	4.53	-	-	-	-
Other Unusual Items	-	-	-	-	-	-0.76
Pretax Income	12.49	5.23	8.76	26.68	23.11	5.87
Income Tax Expense	4.63	2.39	2.61	6.96	7.58	3.11
Earnings From Continuing Operations	7.86	2.84	6.15	19.73	15.53	2.76
Net Income	7.86	2.84	6.15	19.73	15.53	2.76
Net Income to Common	7.86	2.84	6.15	19.73	15.53	2.76
Net Income Growth	-	-53.87%	-68.80%	27.03%	463.67%	-17.54%
Shares Outstanding (Basic)	49	49	49	48	49	48
Shares Outstanding (Diluted)	51	50	50	50	52	50
Shares Change (YoY)	4.35%	-0.25%	-0.49%	-2.58%	3.57%	4.94%
EPS (Basic)	0.16	0.06	0.13	0.41	0.32	0.06
EPS (Diluted)	0.16	0.06	0.12	0.39	0.30	0.06
EPS Growth	-	-51.51%	-69.23%	30.00%	419.61%	-17.52%
Free Cash Flow	-	17.04	8.84	7.72	39.62	42.79
Free Cash Flow Per Share	-	0.34	0.18	0.15	0.77	0.86
Dividend Per Share	0.180	0.180	0.180	0.150	0.090	-
Dividend Growth	-	-	20.00%	66.67%	-	-
Gross Margin	41.77%	39.29%	38.53%	40.74%	39.36%	39.84%
Operating Margin	5.22%	2.33%	5.05%	10.37%	9.09%	4.97%
Profit Margin	3.27%	1.15%	2.11%	6.89%	5.59%	1.11%
Free Cash Flow Margin	-	6.88%	3.04%	2.70%	14.26%	17.18%
EBITDA	17.51	11.65	20.97	35.05	30.6	18.57
EBITDA Margin	7.29%	4.70%	7.21%	12.24%	11.01%	7.45%
D&A For EBITDA	4.97	5.89	6.26	5.37	5.33	6.2
EBIT	12.54	5.76	14.71	29.68	25.27	12.37
EBIT Margin	5.22%	2.33%	5.05%	10.37%	9.09%	4.97%
Effective Tax Rate	37.05%	45.69%	29.76%	26.07%	32.81%	53.05%

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q